How many clinical trials are tracked of tesamorelin?

5 trials are tracked, 0 with published results.

Mode

All Infectious Disease Oncology Neurology Cardiology Psychiatry Diabetes & Endocrinology Pediatrics Allergy & Immunology Rheumatology Gastroenterology Primary Care & Family Medicine Nutrition & Obesity Medicine OB/GYN & Women's Health Orthopedics & Sports Medicine Genetics & Precision Medicine Radiology & Imaging Pulmonology & Critical Care Anesthesiology & Pain Medicine Physical Medicine & Rehab Nephrology Hematology Dermatology Urology Ophthalmology Emergency Medicine Geriatrics & Aging ENT (Otolaryngology) Palliative Care

Research

Clinical Trials Drug Pipeline Weekly Digests

Reference

Conditions Medications

Community

Questions

Text Size

tesamorelin

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of tesamorelin

5 trials tracked of tesamorelin: 1 in phase 3 or 4.

5Trials tracked

1Phase 3 & 4

0Recruiting

0With published results

Phase distribution

Phase 3 1 Phase 2 2 Other / NA 2

Phase 3 TH9507 Extension Study in Patients With HIV-Associated Lipodystrophy Completed
Phase 2 Growth Hormone Releasing Hormone Analog to Improve Nonalcoholic Fatty Liver Disease and Associated Cardiovascular Risk Completed
Phase 2 Phase II Trial of Tesamorelin for Cognition in Aging HIV-Infected Persons Completed
N/A Tesamorelin Effects on Liver Fat and Histology in HIV Completed
N/A Effects of Growth Hormone Releasing Hormone in HIV Completed

Showing the 5 most-cited and recently-updated of 5 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.